Although the number of cases in this study is relatively small (total 108 patients with ovarian tumour), our findings are similar to the results obtained from a breast cancer study that the B2M expression has no significant association with age, lymph node metastasis and clinical stage [29]. The gene discussed is B2M; the disease is breast carcinoma.